WASHINGTON, DC, USA I June 10, 2025 I Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in ...

BOSTON, MA, USA and LAUSANNE, Switzerland I June 10, 2025 I Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces the ...

– Series A financing co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management, with participation from other leading healthcare funds – ...

Presentations will include the latest preclinical data from Factor's engineered iMacrophage program (FACT-112) ...

SINGAPORE and PHILADELPHIA, PA, USA I June 10, 2025 I Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven ...

COPENHAGEN, Denmark I June 10, 2025 I Adcendo, a clinical-stage biotech company pioneering the development of first and best-in-class ADCs for cancers with a ...

TUEBINGEN, Germany I June 10, 2025 I HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver ...

SAN DIEGO, CA, USA I June 10, 2025 I Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to ...

FREISING, Germany I June 10, 2025 I XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has ...

PARIS, France I June 10, 2025 I As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...

JUPITER, FL, USA I June 9, 2025 I Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular ...

MILAN, Italy I June 06, 2025 I Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation for ...